Governance · Risk
Statutory-facing governance instrument — reviewed quarterly by Audit & Risk Committee, annually refreshed by Board

Risk Register — Year 1 populated

The Risk Register is the single document by which the Board demonstrates that it has considered, rated, controlled, and assigned ownership of every material risk facing Life Without Debt Ltd — as required by the Directors' duty of care and diligence under Corporations Act 2001 (Cth) s.180(1) and ACNC Governance Standard 5. This version contains the Y1 populated set of risks identified pre-lodgement; it will be re-baselined at the first Audit & Risk Committee meeting and refreshed each quarter thereafter.

DRAFT v1.0 · For adoption at First Board Meeting · Owner: Audit & Risk Committee
How this register works

Each risk has a unique ID (e.g. R-DAT-01) formed as R-CATEGORY-NN. The ID persists across register versions so a risk can be tracked over time even as its rating changes. Each risk is scored on a 5×5 likelihood × consequence matrix (see §2 for the matrix). The inherent rating is the risk before controls; the residual rating is the risk with current controls operating as designed. Where residual is above the Board's risk appetite, a treatment plan is required.

§1 · Scope, purpose, governance

1.1 Purpose. To provide the Board with a comprehensive, dynamically-maintained view of the risks that could prevent Life Without Debt Ltd from achieving its charitable purpose, and to record the controls, ownership, and treatment plans that manage each risk to a level the Board is willing to accept.

1.2 Authority. Corporations Act 2001 (Cth) s.180(1) (duty of care and diligence); ACNC Governance Standard 5 (duties of Responsible Persons); Board Charter §6.1 (Audit & Risk Committee); Compliance Calendar Y1–Y3 Part E (quarterly review cadence).

1.3 Ownership and cadence.

  • Ultimate owner: Board of Directors.
  • Operational owner: Audit & Risk Committee (reviewing quarterly).
  • Register maintainer: Secretary, with input from CEO and BLO Lead.
  • Individual risk owners: Named on each row.
  • Cadence: Quarterly review by Audit & Risk Committee; annual full refresh at Q4 Board meeting; out-of-cycle refresh triggered by any incident, notifiable data breach, or material change in operations.

§2 · Rating methodology — 5×5 likelihood × consequence

2.1 Likelihood scale (over 12 months):

LevelDescriptorIndicative probability
1Rare<5% (may occur only in exceptional circumstances)
2Unlikely5–25%
3Possible25–50%
4Likely50–80%
5Almost certain>80%

2.2 Consequence scale:

LevelDescriptorFinancial (indicative)Beneficiary / missionRegulatory / reputational
1Insignificant<$5kNo beneficiary impactInternal only
2Minor$5k–$25kIsolated beneficiary inconvenienceComplaint · minor media
3Moderate$25k–$100kBeneficiary services degraded for weeksRegulator inquiry · sector media
4Major$100k–$500kBeneficiary harm; multiple cases affectedRegulator action · mainstream media
5Catastrophic>$500kCharity unable to deliver purpose; individual serious harmACNC deregistration · civil penalty · front-page media

2.3 Rating matrix (likelihood × consequence):

C1 Insig C2 Minor C3 Mod C4 Major C5 Catas
L5 Almost certainMedHighHighExtremeExtreme
L4 LikelyLowMedHighHighExtreme
L3 PossibleLowMedMedHighExtreme
L2 UnlikelyLowLowMedMedHigh
L1 RareLowLowLowMedMed

2.4 Board risk appetite. The Board's default appetite is Low for regulatory, safeguarding, and data-privacy risks; Medium for operational and financial risks in the ordinary course; Low for reputational risks that could affect beneficiary trust. Residuals above appetite require an approved treatment plan and quarterly reporting until back within appetite.

§3 · Risk categories

Risks are grouped into seven categories to make the register navigable and to align ownership with the sub-committee structure.

  • STR — Strategic · risks to LWD's ability to achieve its charitable purpose
  • REG — Regulatory & legal · risks arising from statutory obligations (ACNC, ASIC, ATO, DGR, ACL, Fair Work, Privacy)
  • FIN — Financial · risks to solvency, reserves, funding, and financial integrity
  • OPS — Operational · risks to day-to-day operations (people, systems, third parties)
  • DAT — Data & privacy · risks to the confidentiality, integrity, and availability of beneficiary and donor information
  • SFG — Safeguarding & beneficiary · risks of harm to beneficiaries, families, and staff
  • REP — Reputational · risks to trust with beneficiaries, donors, regulators, and the public

§4 · Risk register — Year 1 populated

Strategic (STR)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-STR-01 ACNC registration refused or delayed PBI subtype eligibility not accepted; charitable purposes drafting challenged 24 Med Solicitor pre-review; ACNC Portal-Ready doc; PBI CIS 29 Sep 2025 aligned; Public Benefit Memo Low Secretary + solicitor
R-STR-02 DGR endorsement refused Gift-fund structure or activities challenged as inconsistent with item 4.1.1 24 Med Constitution cl.26–29 gift-fund provisions; DGR-purpose activities documented; DGR Application Package Low Treasurer + solicitor
R-STR-03 Insufficient founding capital to demonstrate viability Y1 founding-donor round misses target 34 High Three-tier ask ($25k/$100k/$500k+); founding-donor deck & one-pager; case-studies bank; reserves policy target Med CEO + Chair
R-STR-04 Mission drift into activities inconsistent with charitable purpose Pressure to expand into general debt-advocacy for non-terminally-ill population 23 Med Constitution cl.4 (purposes); Board Charter §5.1; Direct Relief Policy eligibility gate Low Board

Regulatory & legal (REG)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-REG-01 ACL trigger crossed unknowingly in Y1 Volume of on-behalf-of hardship engagement with credit providers crosses NCCP s.29 threshold 24 Med Quarterly volume & scope assessment by CEO + solicitor; ACL Application Package pre-drafted; RG 203 test applied Low CEO + solicitor
R-REG-02 Corporations Act director duty breach Undisclosed material personal interest; related-party transaction outside Ch 2E 25 High Register of Interests pre-filled + maintained; Conflicts Policy + Related-Party Policy; Chair's script at first meeting; DAS §5.6 Med Secretary
R-REG-03 ACNC Governance Standard breach Standard 5 duty; Standard 3 (Australian laws); Standard 6 (external conduct) 24 Med Compliance Plan; Compliance Calendar; policy suite; annual Board effectiveness review Low Secretary
R-REG-04 State fundraising authority breach Active fundraising in a state without authority 33 Med NSW/Vic/Qld authorities lodged Y1 Q2; solicitor tracks reciprocal recognition; fundraising channels tagged per state Low Secretary + solicitor
R-REG-05 Late lodgement of AIS / AFR / ASIC review Deadline missed 23 Low Compliance Calendar Y1–Y3 (this document's companion); Secretary's diary; A&R Committee quarterly review Low Secretary

Financial (FIN)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-FIN-01 Insolvent trading Board incurs debt when there are reasonable grounds to suspect the company cannot pay 15 Med Corporations Act s.588G briefing at first meeting; Treasurer monthly cash-flow reporting; Reserves Policy; DAS §5.3 dollar-band thresholds; monthly board dashboard Low Treasurer / CoSai
R-FIN-02 Reserves fall below policy floor Cost overrun; direct-relief demand spike; slow donation cycle 33 Med Reserves Policy floor (6 months operating); quarterly reserves report; direct-relief caps DAS §5.4; Board approval required for >$5k relief Med Treasurer
R-FIN-03 Fraud or misappropriation Internal or external actor diverts funds 15 Med Two-signatory bank rule (DAS §5.7); segregation of duties; external audit/review from Y1 close; fidelity insurance; whistleblower policy Low Treasurer + Chair
R-FIN-04 DGR gift-fund misuse Receipted funds used for non-DGR-purpose activity 24 Med Gift fund ring-fenced in accounting system; annual gift-fund audit trail; Constitution cl.26–29 restrictions; auditor sign-off Low Treasurer

Operational (OPS)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-OPS-01 Key-person dependency CEO (Laurence) or CFO (CoSai/Carla) incapacitated 34 High Documented processes; Board Charter delegation; N&R Committee succession watchlist; independent Chair; sub-committee structure spreads knowledge Med Chair + N&R Chair
R-OPS-02 BLO capacity — beneficiary demand outstrips available casework hours Founding phase; single BLO; case complexity varies 43 High Intake triage per Beneficiary Intake Pack; complexity scoring; warm-referral pathway; quarterly capacity review by Beneficiary Services Committee Med CEO + Beneficiary Services Chair
R-OPS-03 Third-party service provider failure Case management system outage; bank outage; email provider outage 23 Med Australian-hosted providers with SLA; encrypted backups to second region; documented manual fallback for hardship notices; annual restore test Low Secretary + IT provider
R-OPS-04 Insurance gap — D&O, PL, PI, cyber, fidelity Cover not in place at incident date 24 Med All lines bound at Y1 Q1; annual renewal cycle at Y1 Q4 / Y2 Q1; broker review at renewal; Board sights certificates of currency each year Low Secretary

Data & privacy (DAT)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-DAT-01 Notifiable data breach affecting beneficiary health information Phishing; misdirected email; unauthorised access to case management system 25 High Privacy Policy §6 access controls; MFA on all systems; role-based case-file access; encrypted at rest & in transit; NDB response plan; staff training Med Secretary
R-DAT-02 Improper disclosure to a debt collector BLO shares more than minimum necessary; diagnosis specifics leaked 33 Med Privacy Policy §5.2 minimum-disclosure rule for collectors; BLO scripts; supervisory review of first 20 collector communications per BLO Low CEO + Secretary
R-DAT-03 SIS Reg 6.01A medical certificate leak Highly sensitive certificate leaves the restricted sub-folder inappropriately 25 High Privacy Policy §7.1 additional access log; disclosure limited to super trustee only; separate sub-folder; quarterly access-log review by A&R Med Secretary + BLO Lead
R-DAT-04 Retention over-hold Records kept beyond schedule; re-identification of "destroyed" case 33 Med Privacy Policy §11 retention schedule; Records Destruction Register; annual purge job; A&R Committee review Low Secretary

Safeguarding & beneficiary (SFG)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-SFG-01 Beneficiary self-harm or acute mental-health crisis identified during intake Vulnerable population; combined terminal diagnosis + hardship + harassment 35 Extreme Intake Pack Step 6 duty-of-care escalation; BLO trained crisis referral (Lifeline, 1800RESPECT); CEO same-day notification; Privacy Policy §4.2 APP 6.2(c) serious-threat exception High CEO + BLO Lead
R-SFG-02 Elder abuse / financial abuse of a beneficiary detected Family member misappropriating beneficiary funds; coerced consent 34 High BLO trained detection; Elder Abuse Helpline referral; Consent D third-party protocol; direct-relief payments to beneficiary account only (not third-party) Med CEO + Beneficiary Services Chair
R-SFG-03 Family violence disclosed during intake Beneficiary in a coercive household; financial-abuse debts 24 Med Intake Pack Step 6 escalation; safe-contact method flagged in case file; 1800RESPECT referral; case-file access hardening Low BLO Lead
R-SFG-04 BLO vicarious trauma / burnout Repeated exposure to terminally-ill, distressed beneficiaries 43 High External clinical supervision monthly; peer debrief cadence; annual EAP; case-complexity throttling by Beneficiary Services Committee; leave policy Med CEO

Reputational (REP)

ID Risk Cause / event L C Inherent Controls Residual Owner
R-REP-01 Public perception of "picking winners" Case selection appears arbitrary or opaque 33 Med Direct Relief Policy published; eligibility criteria transparent; annual anonymised outcomes report; Beneficiary Services Committee reviews sample Low CEO + Chair
R-REP-02 Founder-related-party perception risk Laurence Hugo's disclosed interests + BLO family interest perceived as self-dealing 33 Med Register of Interests pre-filled + public; Chair's script s.191/192 briefing; Ch 2E recusal on any related-party matter; independent-majority Board target; independent Chair Low Chair + Secretary

§5 · Risk summary — residuals by category

Category Risks logged Residual: Low Residual: Med Residual: High Residual: Extreme Notes
Strategic (STR)43100R-STR-03 (funding round) is the outlier; treated via founding-donor pack
Regulatory (REG)54100R-REG-02 residual Medium — reduce with quarterly conflicts audit
Financial (FIN)43100R-FIN-02 residual Medium; watch reserves ratio at each quarterly meeting
Operational (OPS)42200R-OPS-01, R-OPS-02 both key-person / capacity; treated by N&R + committee structure
Data & privacy (DAT)42200R-DAT-01 & R-DAT-03 highest inherent exposure; controls robust
Safeguarding (SFG)41210R-SFG-01 residual High — Board-noted acceptable residual given population served; monitored by Beneficiary Services Committee
Reputational (REP)22000Founder-related-party (R-REP-02) treated by transparent register + independent Chair
Total2717910All residuals within appetite except R-SFG-01, which is Board-accepted with monitoring
Board-accepted residual above appetite

R-SFG-01 (beneficiary self-harm risk) has a residual rating of High which is above the Board's default appetite for safeguarding. The Board accepts this residual because (a) LWD's population is by definition at elevated distress; (b) the controls in place (immediate crisis referral, same-day CEO notification, APP 6.2(c) exception) represent best practice; and (c) driving the residual below High would require refusing to serve the highest-need beneficiaries, which is inconsistent with LWD's purpose. The residual is reviewed at every quarterly A&R meeting and reported to the Board at every Board meeting.

§6 · Active treatment plans

Treatment plans are opened for each risk with residual above appetite, and closed when the residual is back within appetite. Y1 open plans:

Risk ID Treatment Owner Milestone Status
R-STR-03 Execute founding-donor round using one-pager + deck + case-studies bank; secure at least one Lead Founding Partner or two Founding Patrons by Y1 Q4 CEO + Chair Y1 Q4 pipeline review Open
R-OPS-01 Document all CEO / CFO processes in operating manual; N&R Committee to maintain succession watchlist and consider adding a second BLO in Y2 N&R Chair Y1 Q4 succession review Open
R-OPS-02 Quarterly capacity review; case-complexity throttling; establish warm-referral network with financial counsellors and CLCs by Y1 Q2 Beneficiary Services Chair Y1 Q2 network stood up; ongoing Open
R-SFG-01 Accept residual above appetite; monitor at every A&R meeting; ensure crisis referral SOP is trained annually; consider clinical-social-worker advisor arrangement in Y2 CEO + Beneficiary Services Chair Ongoing Accepted (Board-noted)
R-SFG-04 External clinical supervision monthly for BLOs; peer debrief cadence; annual EAP; case-complexity throttling CEO Y1 Q2 supervision arrangement in place Open

§7 · Adoption and sign-off

Resolution — adoption of Risk Register (Y1 populated):

"That the Board adopts the Risk Register (Y1 populated, Draft v1.0) as the operative risk log of Life Without Debt Ltd, appoints the Audit & Risk Committee as the standing owner of quarterly review, notes and accepts the residual rating of R-SFG-01 above default appetite for the reasons recorded at §5, and confirms that the Register will be tabled at every Board meeting alongside the Compliance Calendar and any active treatment plans."

[Chair name]
Chair
Date: [dd/mm/yyyy]
[Audit & Risk Committee Chair name]
Audit & Risk Chair
Date: [dd/mm/yyyy]
Related documents